JP2020518621A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518621A5
JP2020518621A5 JP2019560254A JP2019560254A JP2020518621A5 JP 2020518621 A5 JP2020518621 A5 JP 2020518621A5 JP 2019560254 A JP2019560254 A JP 2019560254A JP 2019560254 A JP2019560254 A JP 2019560254A JP 2020518621 A5 JP2020518621 A5 JP 2020518621A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
group
cycloalkyl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518621A (ja
JP7788128B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050404 external-priority patent/WO2018201192A1/en
Publication of JP2020518621A publication Critical patent/JP2020518621A/ja
Priority to JP2023101906A priority Critical patent/JP2023134493A/ja
Publication of JP2020518621A5 publication Critical patent/JP2020518621A5/ja
Application granted granted Critical
Publication of JP7788128B2 publication Critical patent/JP7788128B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560254A 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物 Active JP7788128B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023101906A JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017901611 2017-05-03
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
AU2017901647 2017-05-05
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023101906A Division JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Publications (3)

Publication Number Publication Date
JP2020518621A JP2020518621A (ja) 2020-06-25
JP2020518621A5 true JP2020518621A5 (https=) 2025-04-14
JP7788128B2 JP7788128B2 (ja) 2025-12-18

Family

ID=64015663

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560254A Active JP7788128B2 (ja) 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Country Status (9)

Country Link
US (2) US20200079757A1 (https=)
EP (1) EP3619204B1 (https=)
JP (2) JP7788128B2 (https=)
CN (1) CN110753688A (https=)
AU (3) AU2018262108A1 (https=)
ES (1) ES3049333T3 (https=)
FI (1) FI3619204T3 (https=)
PT (1) PT3619204T (https=)
WO (1) WO2018201192A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases
JP7614646B2 (ja) * 2018-11-07 2025-01-16 ティアンリ バイオテック プロプライエタリ リミテッド 呼吸器疾患の処置のための化合物及び組成物
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
AU1924699A (en) * 1997-12-19 1999-07-12 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
SI2493876T1 (sl) * 2009-10-28 2014-04-30 Pfizer Inc. Derivati imidazola kot inhibitorji kazein-kinaze
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
WO2016149756A1 (en) * 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases

Similar Documents

Publication Publication Date Title
US9181223B2 (en) 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
US9382228B2 (en) N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2024166311A (ja) 化合物、組成物、及び、方法
CN111989332A (zh) 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用
JP2018515495A5 (https=)
JP2021523200A5 (https=)
JP2023508982A5 (https=)
JP2017518959A5 (https=)
TW201204346A (en) Novel hydroxamic acid derivative
JP2016534063A5 (https=)
JP2020518621A5 (https=)
JP2019500387A5 (https=)
US20230348437A1 (en) Compounds, compositions and methods
JP2019535723A5 (https=)
PH12019550083A1 (en) Inhibitors of bruton's tyrosine kinase
WO2017112853A1 (en) Methods of treating pulmonary diseases and disorders
JP2022533958A5 (https=)
JP2014502599A5 (https=)
JP2020516616A5 (https=)
JP2019500376A5 (https=)
AU2020338985A1 (en) Substituted urea dihydroorotate dehydrogenase inhibitors
JP2012509313A5 (https=)
JP2018529649A5 (https=)
JP2017522383A5 (https=)
WO2019166950A1 (en) 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza